Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

The prescribing of low doses of quetiapine for the treatment of sleeping disorders appears to be widespread. Recently, in a systematic literature review on low-dose quetiapine use for the treatment of sleeping disorders, it was concluded that evidence for its efficacy is currently lacking. Furthermore, quetiapine is probably associated with potentially severe adverse effects, also at low doses. In conclusion, sufficient scientific evidence that justifies the current practice of off-label prescribing of low-dose quetiapine for the treatment of sleeping disorders is insufficient; further research into its efficacy and safety is needed.

Citation

Lineke M Tak, Inge R F van Berlo-van de Laar, Bennard Doornbos. No quetiapine for sleeping disorders]. Nederlands tijdschrift voor geneeskunde. 2013;157(4):A5740

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 23343742

View Full Text